Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: A possible relation to disease invasion

Hematology

Volumn 8, Issue 6, 2003, Pages 385-391

  Aref, Salah ^a   El Sherbiny, M ^b   Mabed, M ^a   Menessy, A ^a   El Refaei, M ^c  

^a MANSOURA UNIVERSITY   (Egypt)

^b NATIONAL CANCER INSTITUTE   (Egypt)

^c MENOUFIA UNIVERSITY   (Egypt)

Author keywords

AML; Metalloproteinase 9; suPAR; Urokinase plasminogen activator receptor

Indexed keywords

BIOLOGICAL MARKER; CYTARABINE; ETOPOSIDE; GELATINASE B; IDARUBICIN; METALLOPROTEINASE; MITOXANTRONE; PROTEINASE; UROKINASE; UROKINASE RECEPTOR; MMP9 PROTEIN, HUMAN; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HUMAN; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SOLUBILITY; CASE CONTROL STUDY; ENZYMOLOGY; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR INVASION;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0346463271     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245330310001621323     Document Type: Article

References (28)

1. Lin, L.I., Lin, D.T., Chang, C.J., Lee, C.Y., Tang, J.L. and Tien, H.F. (2002) "Marrow matrix metalloproteinase (MMPs) and tissue inhibitors of MMP in acute leukemia: Potential role of MMP-9 as a surrogate marker to monitor leukemic status in patients with acute myelogenous leukemia", Br. J. Hematol. 117(4), 835-841.
2. Ries, C., Loher, F., Zang, C., Ismair, M.G. and Petrides, P.E. (1999) "Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes", Clin. Cancer Res. 5(5), 1115-1124.
3. Pauli, B.U., Schwartz, D.E., Thonar, E.J. and Kuettner, K.E. (1983) "Tumor invasion and host extracellular matrix", Cancer Metastasis Rev. 2(2), 129-152.
4. Moscatelli, D. and Rifkin, D.B. (1988) "Membrane and matrix localization of proteinases; a common theme in tumor cell invasion and angiogenesis", Biochem. Biophys. Acta 948(1), 67-85.
5. Lanaza, F., Castoldi, G.L., Castagnari, B., Todd, R.F., Moretti, S., Spisani, S., Latorraca, A., Focarile, E., Roberti, M.G. and Traniello, S. (1998) "Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukemic cells", Br. J. Hematol. 103(1), 110-123.
6. Bajou, K. (2002) "Role of PAI-1 plasminogen activator inhibitor in tumor invasion and angiogenesis", Bull. Mem. Acad. R. Med. Belg. 157(5-6), 313-318.
7. Zhao, W., Wang, X., Qu, B., Huang, X. and Wang, H. (2002) "Clinical significance of plasma tissue factor pathway and urokinase-type plasminogen activator system in cancer patients", Chin. Med. J. (Engl.) 115(5), 702-704.
8. Liotta, L.A. and Stetler-Stevenson, W.G. (1991) "Tumor invasion and metastasis: an imbalance of positive and negative regulation", J. Cancer Res. 51(Suppl. 18), 5054s-5059s.
9. Zucker, S., Lysik, R.M., diMassimo, B.I., Zarrabi, H.M., Moll, U.M., Grimson, R., Tickle, S.P., and Docherty, A.J. (1995) "Plasma assay of glatinase B: tissue inhibitor of metalloproteinase complexes in cancer", Cancer 76(4), 700-708.
10. Ries, C. and Petrides, P.E. (1995) "Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease", Biol. Chem. Hoppe-Seyler 376(6), 345-355.
11. Tieghi, A., Ciccone, M., Bragotti, Z.L., cavazzini, F., Porta, M.D., Castagnari, B., Carroccia, R., Guerra, G., Cuneo, A. and Castoldi, G. (2003) "Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma", Br. J. Hematol. 120(6), 953-959.
12. Mori, N., Sato, H., Hayashibara, T., Senba, M., Hayashi, T., Yamada, Y., Kamihira, S., Ikeda, S., Yamasaki, Y., Morikawa, S., Tomonaga, M., Geleziunas, G. and Yamamoto, N. (2001) "Human T-cell leukemia virus Type I Tax transactivates the matrix metalloproteinase 9 gene:potential role in mediating adult T-cell leukemia invasiveness", Blood 99(4), 1341-1349.
13. Jensen, M.K., Riisbro, R., de Nullly Brown, P., Brunner, N. and Hasselbach, H.C. (2002) "Elevated soluble urokinase plasminogen activator receptor in plasma from patients with idiopathic myelofibrosis or polycythemia vera", Eur. J. Hematol. 69(1), 43-49.
14. Hayashibara, T., Ymada, Y., Onimaru, Y., Tsutsumi, C., Nakayama, S., Mori, N., Miyanishi, T., Kamihira, S., Tomonaga, M. and Maita, T. (2002) "Matrix metalloproteinase-9 and vascular endothelial growth factor. A possible link in adult T-cell leukemia cell invasion", Br. J. Hematol. 116(1), 94-102.
15. Guan, K.P., Ye, H.Y., Yan, Z., Wang, Y. and Hou, S.K. (2003) "Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of bladder", Urology 61(4), 719-723.
16. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. and Sultan, C. (1985) "Proposed revised criteria for classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group", Ann. Intern. Med. 103(4 , 620-625.
17. Cheson, B.D., Cassilteth, P.A., Head, D.R., Schiffer, C.A., Bennet, J.M. and Bloomfield, C.D. (1990) "Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia", J. Clin. Oncol. 8(5), 813-819.
18. Bene, M.C., Castoldi, G., Knapp, W., Ludwing, W.D., Matutes, E. and Orfao, A. (1995) "European Group for immunological classification of acute leukemias", Leukemia 9(10), 1783-1786.
19. Munoz, L., Aveentin, A., Villamor, N., Junca, J., Acebedo, G., Domingo, A., Rozman, M., Torres, J.P., Tormo, M. and Nomdedeu, J.F. (2003) "Immunophenotypic findings in acute leukemia with Flt3 internal Tandem duplication", Hematologica 88(6), 637-645.
20. Stephens, R.W., Pedersen, A., Nielsen, H.J., Hamers, M., Hoyer-Hansen, G., Ronne, E., Dybkjaer, E., Dane, K. and Brunner, N. (1997) "ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients", Clin. Chem. 43(10), 1868-1876.
21. Ronne, E., Pappot, H., Grondahl-Hansen, J., Hoyer-Hansen, G., Plesner, T., Hansen, N.E. and Dano, K. (1995) "The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal hemoglobinuria", Br. J. Hematol. 89(3), 576-581.
22. Wahlberg, K., Hoyer-Hansen, G. and Casslen, B. (1998) "Soluble receptor for urokinase plasminogen length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer", Cancer Res. 58(15), 3294-3298.
23. Sier, C.F., Sidenius, N., Mariani, A., Aletti, G., Agape, V., Ferrari, A., Casetta, G., Stephens, R.W., Brunner, N. and Blasi, F. (1999) "Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance", Lab. Investig. 79(6), 717-722.
24. Janowska-Wieczorek, A., Marquez, L.A., Matsuzaki, A., Hashmi, H.R., Larratt, L.M., Boshkov, L.M., Turner, A.R., Zhang, M.C., Edwards, D.R. and Kossakowska, A.E. (1999) "Expression of matrix metalloproteinases (MMP-2 and MMP-9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukemia blasts: comparison with normal bone marrow cells", Br. J. Hematol 105(2), 402-411.
25. Goetzl, E.J., Banda, M.J. and Leeppert, D. (1996) "Matrix metalloproteinases; in immunity", J. Immunol. 156(1), 1-4.
26. Delclaux, C., Delacourt, C., D'Ortho, M., Boyer, V., Lafuma, C. and Harf, A. (1996) "Role of gelatinase B and elastase in human polymorph nuclear neutrophil migration across basement membrane", Am. J. Respir. Cell Mol. Biol. 14(3), 288-295.
27. Matsuzaki, A. and Janowska-Wieczorek, A. (1997) "Unstimulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases", J. Cancer Res. Clin. Oncol. 123(2), 100-106.
28. Mustjoki, S., Sidenius, N., Sier, C.F.M., Blasi, F., Elonen, E., Alitalo, R. and Vaheri, A. (2000) "Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy", Cancer Res. 60(15), 7126-7132.